Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

   141,861,898      
Direct Value   $82,119,756    

Indirect Value

   $12,961,771,173      
Total Shares   142,789,105      
Total Value   $13,043,890,929      


Incyte Corp $32,589,847 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $312,474 Neurogene $16,634 Incyte Corp $32,589,847 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $312,474 Neurogene $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    36   
    6    

     Stock price went up :
    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 48 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SGEN Seagen Inc Director   –       •       •   2005-04-29 4 B $3.99 $357,560 I/I 89,394 381,397 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-14 4 B $7.41 $664,603 I/I 89,632 6,470,110 1.5 -
SGEN Seagen Inc Director   –       •       •   2008-02-08 4 B $8.94 $807,257 I/I 89,682 7,602,426 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2011-06-09 4 B $26.25 $2,360,109 I/I 89,891 6,059,449 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2007-05-29 4 B $16.39 $1,481,771 I/I 90,428 3,158,067 2.25 -
INCY Incyte Corp Director   –       •       •   2008-01-09 4 B $10.94 $991,319 I/I 90,591 5,361,109 2.25 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-02-03 4 B $6.29 $573,311 I/I 91,187 12,824,440 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2012-03-02 4 B $29.52 $2,699,915 I/I 91,459 8,058,823 2.25 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-02-02 4 B $6.52 $598,360 I/I 91,728 12,733,253 1.5 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-01-19 4 B $7.12 $656,750 I/I 92,200 12,393,685 1.5 -
KOD Kodiak Sciences Inc. Director   –       •       •   2022-05-26 4 B $6.71 $628,583 I/I 93,322 15,316,021 2.25 %
OCRX Ocera Therapeutics Inc 10% Owner   –       –       •   2012-03-12 4 B $1.87 $229,685 I/I 94,306 204,336 1.5 -
KOD Kodiak Sciences Inc. Director   –       •       •   2022-02-16 4 B $53.73 $5,150,173 I/I 95,165 14,457,794 2.25 %
VPHM Viropharma Inc 10% Owner   –       –       •   2010-04-29 4/A B $12.98 $1,245,591 I/I 95,686 299,837 1.5 -
SGEN Seagen Inc Director   –       •       •   2008-01-23 4 B $9.03 $864,105 I/I 95,716 7,487,000 2.25 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2008-11-20 4 B $1.00 $96,033 I/I 96,033 1,746,323 1.5 -
VPHM Viropharma Inc 10% Owner   –       –       •   2009-05-11 4 B $5.86 $566,654 I/I 96,725 6,486,532 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2008-06-05 4 B $19.50 $1,899,293 I/I 96,863 3,268,072 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2011-12-02 4 B $28.03 $2,729,234 I/I 97,295 6,881,247 2.25 -
VPHM Viropharma Inc 10% Owner   –       –       •   2006-02-28 4 S $19.90 $1,955,461 I/I (97,439) 1,648,599 -
SGEN Seagen Inc Director   –       •       •   2006-06-27 4 B $4.03 $394,570 I/I 97,745 3,415,877 2.25 -
VPHM Viropharma Inc 10% Owner   –       –       •   2010-05-07 4 S $12.46 $1,220,176 I/I (97,940) 2,751,095 0 -
VPHM Viropharma Inc 10% Owner   –       –       •   2006-02-27 4 S $21.58 $2,135,616 I/I (98,334) 1,746,038 -
GEVA Synageva BioPharma Corp Director   –       •       •   2015-06-22 4 A $0.00 $0 D/D 99,503 100,003 0 -
INCY Incyte Corp Director   –       •       •   2022-02-22 4 B $68.07 $6,793,536 I/I 99,800 33,039,604 2.25 %
  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48  49   50   51   52   53   54   55   56      
  Page 48 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us